Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用
2-Hydroxy Cabozantinib is a metabolite of cabozantinib (CAS# 849217-68-1), which is a tyrosine kinase inhibitor and an anticancer drug used in the treatment of thyroid cancer, renal cell carcinoma and hepatocellular carcinoma.
参考文献
Aftab, D. T., et al.: PCT Int. Appl., 65pp. (2014); Viola, D., et al.: Future Oncol., 9, 1083 (2013); Sherman, S. I., et al.: Cancer (Hoboken, NJ, U. S.), 122, 3856 (2016); Wiecek, W., et al.: PLoS One, 11, 0155389/1 (2016); Chuma, M., et al.: Hepatol. Res., 45, E1 (2015)
沪ICP备17019645号
400-821-0725
